Literature DB >> 29103612

Composition and Regulation of the Cellular Repertoire of SCF Ubiquitin Ligases.

Justin M Reitsma1, Xing Liu1, Kurt M Reichermeier1, Annie Moradian2, Michael J Sweredoski2, Sonja Hess2, Raymond J Deshaies3.   

Abstract

SCF (Skp1-Cullin-F-box) ubiquitin ligases comprise several dozen modular enzymes that have diverse roles in biological regulation. SCF enzymes share a common catalytic core containing Cul1Rbx1, which is directed toward different substrates by a variable substrate receptor (SR) module comprising 1 of 69 F-box proteins bound to Skp1. Despite the broad cellular impact of SCF enzymes, important questions remain about the architecture and regulation of the SCF repertoire, including whether SRs compete for Cul1 and, if so, how this competition is managed. Here, we devise methods that preserve the in vivo assemblages of SCF complexes and apply quantitative mass spectrometry to perform a census of these complexes (the "SCFome") in various states. We show that Nedd8 conjugation and the SR exchange factor Cand1 have a profound effect on shaping the SCFome. Together, these factors enable rapid remodeling of SCF complexes to promote biased assembly of SR modules bound to substrate.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CRL; Cop9 signalosome; E3 ligase; MRM; SRM; cullin-RING; proteasome; ubiquitin

Mesh:

Substances:

Year:  2017        PMID: 29103612      PMCID: PMC5711595          DOI: 10.1016/j.cell.2017.10.016

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  69 in total

1.  TIP120A associates with cullins and modulates ubiquitin ligase activity.

Authors:  Kyoeng-Woo Min; Ji-Won Hwang; Jong-Sik Lee; Yoon Park; Taka-aki Tamura; Jong-Bok Yoon
Journal:  J Biol Chem       Date:  2003-02-27       Impact factor: 5.157

2.  The molecular basis of CRL4DDB2/CSA ubiquitin ligase architecture, targeting, and activation.

Authors:  Eric S Fischer; Andrea Scrima; Kerstin Böhm; Syota Matsumoto; Gondichatnahalli M Lingaraju; Mahamadou Faty; Takeshi Yasuda; Simone Cavadini; Mitsuo Wakasugi; Fumio Hanaoka; Shigenori Iwai; Heinz Gut; Kaoru Sugasawa; Nicolas H Thomä
Journal:  Cell       Date:  2011-11-23       Impact factor: 41.582

3.  Substrate binding promotes formation of the Skp1-Cul1-Fbxl3 (SCF(Fbxl3)) protein complex.

Authors:  Kanae Yumimoto; Tetsuya Muneoka; Tomohiro Tsuboi; Keiichi I Nakayama
Journal:  J Biol Chem       Date:  2013-09-30       Impact factor: 5.157

4.  C. elegans CAND-1 regulates cullin neddylation, cell proliferation and morphogenesis in specific tissues.

Authors:  Dimple R Bosu; Hui Feng; Kyoengwoo Min; Youngjo Kim; Matthew R Wallenfang; Edward T Kipreos
Journal:  Dev Biol       Date:  2010-07-24       Impact factor: 3.582

5.  Generation of germline-competent induced pluripotent stem cells.

Authors:  Keisuke Okita; Tomoko Ichisaka; Shinya Yamanaka
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

6.  An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer.

Authors:  Teresa A Soucy; Peter G Smith; Michael A Milhollen; Allison J Berger; James M Gavin; Sharmila Adhikari; James E Brownell; Kristine E Burke; David P Cardin; Stephen Critchley; Courtney A Cullis; Amanda Doucette; James J Garnsey; Jeffrey L Gaulin; Rachel E Gershman; Anna R Lublinsky; Alice McDonald; Hirotake Mizutani; Usha Narayanan; Edward J Olhava; Stephane Peluso; Mansoureh Rezaei; Michael D Sintchak; Tina Talreja; Michael P Thomas; Tary Traore; Stepan Vyskocil; Gabriel S Weatherhead; Jie Yu; Julie Zhang; Lawrence R Dick; Christopher F Claiborne; Mark Rolfe; Joseph B Bolen; Steven P Langston
Journal:  Nature       Date:  2009-04-09       Impact factor: 49.962

7.  F-box-directed CRL complex assembly and regulation by the CSN and CAND1.

Authors:  Michael W Schmidt; Philip R McQuary; Susan Wee; Kay Hofmann; Dieter A Wolf
Journal:  Mol Cell       Date:  2009-09-11       Impact factor: 17.970

8.  Using iRT, a normalized retention time for more targeted measurement of peptides.

Authors:  Claudia Escher; Lukas Reiter; Brendan MacLean; Reto Ossola; Franz Herzog; John Chilton; Michael J MacCoss; Oliver Rinner
Journal:  Proteomics       Date:  2012-04       Impact factor: 3.984

9.  Cdc53/cullin and the essential Hrt1 RING-H2 subunit of SCF define a ubiquitin ligase module that activates the E2 enzyme Cdc34.

Authors:  J H Seol; R M Feldman; W Zachariae; A Shevchenko; C C Correll; S Lyapina; Y Chi; M Galova; J Claypool; S Sandmeyer; K Nasmyth; R J Deshaies; A Shevchenko; R J Deshaies
Journal:  Genes Dev       Date:  1999-06-15       Impact factor: 12.890

10.  Glutamine Triggers Acetylation-Dependent Degradation of Glutamine Synthetase via the Thalidomide Receptor Cereblon.

Authors:  T Van Nguyen; J Eugene Lee; Michael J Sweredoski; Seung-Joo Yang; Seung-Je Jeon; Joseph S Harrison; Jung-Hyuk Yim; Sang Ghil Lee; Hiroshi Handa; Brian Kuhlman; Ji-Seon Jeong; Justin M Reitsma; Chul-Seung Park; Sonja Hess; Raymond J Deshaies
Journal:  Mol Cell       Date:  2016-03-17       Impact factor: 17.970

View more
  49 in total

1.  Suramin and NF449 are IP5K inhibitors that disrupt inositol hexakisphosphate-mediated regulation of cullin-RING ligase and sensitize cancer cells to MLN4924/pevonedistat.

Authors:  Xiaozhe Zhang; Shaodong Shi; Yang Su; Xiaoli Yang; Sining He; Xiuyan Yang; Jing Wu; Jian Zhang; Feng Rao
Journal:  J Biol Chem       Date:  2020-06-03       Impact factor: 5.157

2.  Regulation of Cullin-RING E3 ligase dynamics by Inositol hexakisphosphate.

Authors:  Daniel C Scott; Gary Kleiger
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-10       Impact factor: 11.205

3.  Cand1-Mediated Adaptive Exchange Mechanism Enables Variation in F-Box Protein Expression.

Authors:  Xing Liu; Justin M Reitsma; Jennifer L Mamrosh; Yaru Zhang; Ronny Straube; Raymond J Deshaies
Journal:  Mol Cell       Date:  2018-03-01       Impact factor: 17.970

Review 4.  Monitoring protein communities and their responses to therapeutics.

Authors:  Hanna G Budayeva; Donald S Kirkpatrick
Journal:  Nat Rev Drug Discov       Date:  2020-03-05       Impact factor: 84.694

5.  Vaccinia Virus C9 Ankyrin Repeat/F-Box Protein Is a Newly Identified Antagonist of the Type I Interferon-Induced Antiviral State.

Authors:  Ruikang Liu; Bernard Moss
Journal:  J Virol       Date:  2018-04-13       Impact factor: 5.103

6.  A Structure-Based Strategy for Engineering Selective Ubiquitin Variant Inhibitors of Skp1-Cul1-F-Box Ubiquitin Ligases.

Authors:  Maryna Gorelik; Noah Manczyk; Alevtina Pavlenco; Igor Kurinov; Sachdev S Sidhu; Frank Sicheri
Journal:  Structure       Date:  2018-07-19       Impact factor: 5.006

7.  Rational discovery of molecular glue degraders via scalable chemical profiling.

Authors:  Sophie Bauer; Matthias Brand; Cristina Mayor-Ruiz; Zuzanna Kozicka; Marton Siklos; Hana Imrichova; Ines H Kaltheuner; Elisa Hahn; Kristina Seiler; Anna Koren; Georg Petzold; Michaela Fellner; Christoph Bock; André C Müller; Johannes Zuber; Matthias Geyer; Nicolas H Thomä; Stefan Kubicek; Georg E Winter
Journal:  Nat Chem Biol       Date:  2020-08-03       Impact factor: 15.040

8.  Skp1 Dimerization Conceals Its F-Box Protein Binding Site.

Authors:  Hyun W Kim; Alexander Eletsky; Karen J Gonzalez; Hanke van der Wel; Eva-Maria Strauch; James H Prestegard; Christopher M West
Journal:  Biochemistry       Date:  2020-04-13       Impact factor: 3.162

Review 9.  Cullin 3-Based Ubiquitin Ligases as Master Regulators of Mammalian Cell Differentiation.

Authors:  Wolfgang Dubiel; Dawadschargal Dubiel; Dieter A Wolf; Michael Naumann
Journal:  Trends Biochem Sci       Date:  2017-12-14       Impact factor: 13.807

10.  Basis for metabolite-dependent Cullin-RING ligase deneddylation by the COP9 signalosome.

Authors:  Hong Lin; Xiaozhe Zhang; Li Liu; Qiuyu Fu; Chuanlong Zang; Yan Ding; Yang Su; Zhixue Xu; Sining He; Xiaoli Yang; Xiayun Wei; Haibin Mao; Yasong Cui; Yi Wei; Chuanzheng Zhou; Lilin Du; Niu Huang; Ning Zheng; Tao Wang; Feng Rao
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.